Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Monoclonal Antibody for Multiple Myeloma market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Monoclonal Antibody for Multiple Myelomamarket, defines the market attractiveness level of Monoclonal Antibody for Multiple Myeloma market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Monoclonal Antibody for Multiple Myeloma industry, describes the types of Monoclonal Antibody for Multiple Myeloma market, the applications of major players and the market size, and deeply analyzes the current situation of the global Monoclonal Antibody for Multiple Myeloma market and the development prospects and opportunities of Monoclonal Antibody for Multiple Myeloma industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Monoclonal Antibody for Multiple Myeloma market in Chapter 13.
By Player:
Janssen Biotech
Abbvie
Roche
Seattle Genetics
Karyopharm Therapeutics
PDL BioPharma
Bristol Myers Squibb
By Type:
Elotuzumab
Daratumumab
Siltuximab
Dacetuzumab
Rituximab
Other
By End-User:
Hospital
Drug Center
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Monoclonal Antibody for Multiple Myeloma Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Monoclonal Antibody for Multiple Myeloma Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Monoclonal Antibody for Multiple Myeloma Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Monoclonal Antibody for Multiple Myeloma Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Monoclonal Antibody for Multiple Myeloma Market Analysis and Outlook to 2022
-
7.1 Global Monoclonal Antibody for Multiple Myeloma Consumption (2017-2022)
-
7.2 United States Monoclonal Antibody for Multiple Myeloma Consumption (2017-2022)
-
7.3 Europe Monoclonal Antibody for Multiple Myeloma Consumption (2017-2022)
-
7.4 China Monoclonal Antibody for Multiple Myeloma Consumption (2017-2022)
-
7.5 Japan Monoclonal Antibody for Multiple Myeloma Consumption (2017-2022)
-
7.6 India Monoclonal Antibody for Multiple Myeloma Consumption (2017-2022)
-
7.7 South Korea Monoclonal Antibody for Multiple Myeloma Consumption (2017-2022)
8 Region and Country-wise Monoclonal Antibody for Multiple Myeloma Market Analysis and Outlook to 2028
-
8.1 Global Monoclonal Antibody for Multiple Myeloma Consumption Forecast (2022-2028)
-
8.2 United States Monoclonal Antibody for Multiple Myeloma Consumption Forecast (2022-2028)
-
8.3 Europe Monoclonal Antibody for Multiple Myeloma Consumption Forecast (2022-2028)
-
8.4 China Monoclonal Antibody for Multiple Myeloma Consumption Forecast (2022-2028)
-
8.5 Japan Monoclonal Antibody for Multiple Myeloma Consumption Forecast (2022-2028)
-
8.6 India Monoclonal Antibody for Multiple Myeloma Consumption Forecast (2022-2028)
-
8.7 South Korea Monoclonal Antibody for Multiple Myeloma Consumption Forecast (2022-2028)
9 Global Monoclonal Antibody for Multiple Myeloma Market Outlook by Types and Applications to 2022
-
9.1 Global Monoclonal Antibody for Multiple Myeloma Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Elotuzumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Daratumumab Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Siltuximab Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Dacetuzumab Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Rituximab Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Monoclonal Antibody for Multiple Myeloma Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug Center Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Monoclonal Antibody for Multiple Myeloma Market Outlook by Types and Applications to 2028
-
10.1 Global Monoclonal Antibody for Multiple Myeloma Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Elotuzumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Daratumumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Siltuximab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Dacetuzumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Rituximab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Monoclonal Antibody for Multiple Myeloma Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Monoclonal Antibody for Multiple Myeloma Import and Export Analysis (Top 5 Countries)
-
11.1 Global Monoclonal Antibody for Multiple Myeloma Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Monoclonal Antibody for Multiple Myeloma Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Monoclonal Antibody for Multiple Myeloma Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Monoclonal Antibody for Multiple Myeloma Market Competitive Analysis
-
14.1 Janssen Biotech
-
14.1.1 Janssen Biotech Company Details
-
14.1.2 Janssen Biotech Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Janssen Biotech Monoclonal Antibody for Multiple Myeloma Product and Service
-
14.2 Abbvie
-
14.2.1 Abbvie Company Details
-
14.2.2 Abbvie Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbvie Monoclonal Antibody for Multiple Myeloma Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Monoclonal Antibody for Multiple Myeloma Product and Service
-
14.4 Seattle Genetics
-
14.4.1 Seattle Genetics Company Details
-
14.4.2 Seattle Genetics Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Seattle Genetics Monoclonal Antibody for Multiple Myeloma Product and Service
-
14.5 Karyopharm Therapeutics
-
14.5.1 Karyopharm Therapeutics Company Details
-
14.5.2 Karyopharm Therapeutics Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Karyopharm Therapeutics Monoclonal Antibody for Multiple Myeloma Product and Service
-
14.6 PDL BioPharma
-
14.6.1 PDL BioPharma Company Details
-
14.6.2 PDL BioPharma Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 PDL BioPharma Monoclonal Antibody for Multiple Myeloma Product and Service
-
14.7 Bristol Myers Squibb
-
14.7.1 Bristol Myers Squibb Company Details
-
14.7.2 Bristol Myers Squibb Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol Myers Squibb Monoclonal Antibody for Multiple Myeloma Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Monoclonal Antibody for Multiple Myeloma
-
Figure Monoclonal Antibody for Multiple Myeloma Picture
-
Table Global Monoclonal Antibody for Multiple Myeloma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Monoclonal Antibody for Multiple Myeloma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Monoclonal Antibody for Multiple Myeloma Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Monoclonal Antibody for Multiple Myeloma Consumption by Country (2017-2022)
-
Figure United States Monoclonal Antibody for Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Table Europe Monoclonal Antibody for Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Figure China Monoclonal Antibody for Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Figure Japan Monoclonal Antibody for Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Figure India Monoclonal Antibody for Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Figure South Korea Monoclonal Antibody for Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibody for Multiple Myeloma Consumption Forecast by Country (2022-2028)
-
Figure United States Monoclonal Antibody for Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Monoclonal Antibody for Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Monoclonal Antibody for Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Monoclonal Antibody for Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Monoclonal Antibody for Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Monoclonal Antibody for Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Elotuzumab Consumption and Growth Rate (2017-2022)
-
Figure Global Daratumumab Consumption and Growth Rate (2017-2022)
-
Figure Global Siltuximab Consumption and Growth Rate (2017-2022)
-
Figure Global Dacetuzumab Consumption and Growth Rate (2017-2022)
-
Figure Global Rituximab Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Center Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Elotuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Daratumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Siltuximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dacetuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rituximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Monoclonal Antibody for Multiple Myeloma Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Monoclonal Antibody for Multiple Myeloma Export by Region (Top 5 Countries) (2017-2028)
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Monoclonal Antibody for Multiple Myeloma Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Monoclonal Antibody for Multiple Myeloma Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Monoclonal Antibody for Multiple Myeloma Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Monoclonal Antibody for Multiple Myeloma Product and Service
-
Table Karyopharm Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Karyopharm Therapeutics Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Karyopharm Therapeutics Monoclonal Antibody for Multiple Myeloma Product and Service
-
Table PDL BioPharma (Foundation Year, Company Profile and etc.)
-
Table PDL BioPharma Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
Table PDL BioPharma Monoclonal Antibody for Multiple Myeloma Product and Service
-
Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Monoclonal Antibody for Multiple Myeloma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Monoclonal Antibody for Multiple Myeloma Product and Service
-
